KFDA Releases Advisory Statement on Methotrexate

The Korea Food and Drug Administration (KFDA) released an advisory statement on February 14th to the healthcare professionals and pharmacists on the reported mortality instances in Japan by medications containing methotrexate, which is indicated for treatment of certain types of cancer and of inflammatory arthritis.

The decision to release the advisory statement on methotrexate is based on ...